Epigenetic profiling and eradication of relapse-initiating cells in paediatric acute lymphoblastic leukaemia

Project Member(s): Beck, D.

Funding or Partner Organisation: National Health & Medical Research Council (National Health Medical Research Council)
National Health & Medical Research Council (National Health Medical Research Council)

Start year: 2020

Summary: Acute lymphoblastic leukaemia (ALL) is the most common childhood cancer and remains one of the most common causes of death from disease in children. Even though current treatments are effective in treating ALL, a small fraction of ALL cells may still survive after treatment. The cells that survive, even if only a single cell, can cause recurrence of ALL with low survival rates. This project aims to use cutting edge singlecell technology to identify and eliminate cells causing relapse in ALL.

FOR Codes: Haematology, Blood Disorders, Clinical health

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.